Optina Diagnostics builds molecular ocular imaging systems based on novel technologies to improve patient health through early diagnosis of disease and by improved patient treatment monitoring. Optina Diagnostics is dedicated to leading Ocular imaging with its unique spectral technology. The company’s core imaging technologies hold great promise for early diagnostics of age related macular degeneration and ocular diabetic retinopathy.
Optina Diagnostic IRIS is the first ocular imager commercially available (under investigational used) to offer confortable, reproducible and high contrast super-spectral imaging. IRIS delivers quantitative measurements capable of identifying multiple metabolic processes.
Optina Diagnostic IRIS is the first ocular imager commercially available (under investigational used) to offer confortable, reproducible and high contrast super-spectral imaging. IRIS delivers quantitative measurements capable of identifying multiple metabolic processes.
Location: Canada, Montreal (06), Montreal
Employees: 11-50
Phone: +1 438-828-1675
Total raised: $26.1M
Founded date: 2011
Investors 5
| Date | Name | Website |
| - | Advisors.F... | advisors.f... |
| - | Zoic Capit... | zoiccapita... |
| - | Canadian T... | ctaconnect... |
| 01.06.2021 | Creative D... | creativede... |
| - | CTS | ctssante.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.01.2022 | - | $2.1M | - |
| 28.10.2021 | Series A | $24M | - |
Mentions in press and media 15
| Date | Title | Description |
| 24.01.2022 | Optina Raises US$2.1M in Funding | Optina, a Montreal, Canada-based diagnostics company focused on retinal imaging, brain health and systemic disease detection, closed an up to US$2.1M funding round. The Alzheimer’s Drug Discovery Foundation (ADDF) made the investment throug... |
| 24.01.2022 | Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation (ADDF) | MONTREAL, Jan. 24, 2022 /PRNewswire/ -- Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer's Drug Discov... |
| 01.11.2021 | Optina Diagnostics nabs Boehringer's support in $20M VC round for retina-based Alzheimer's test | Because there’s no single FDA-approved test to diagnose Alzheimer’s disease, physicians typically have to spend months or even years using the process of elimination to rule out a host of other conditions before doling out a definitive diag... |
| 01.11.2021 | Optina Diagnostics nabs Boehringer’s support in $20M VC round for retina-based Alzheimer’s test | Because there’s no single FDA-approved test to diagnose Alzheimer’s disease, physicians typically have to spend months or even years using the process of elimination to rule out a host of other conditions before doling out a definitive diag... |
| 29.10.2021 | The lines between VCs and other investors are getting blurry | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Happy Friday, Term Sheet readers. Finance reporter Anne Sraders here, filling in for Lucinda (she... |
| 29.10.2021 | Optina raises $24 million to bolster AI-powered early Alzheimer detection device | Montréal-based healthtech startup Optina Diagnostics has raised $24 million CAD in its Series A funding round. The financing was led by DigitalDx Ventures, a woman-owned venture capital fund in Silicon Valley focused on investing in compani... |
| 28.10.2021 | Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million | This round was led by DigitalDx Ventures and supported by Boehringer Ingelheim Venture Fund Other investors include Desjardins Capital, Hike Ventures, Advisors Fund, MEDTEQ+ and Biomed Propulsion (participative debt) New funding will suppor... |
| 28.10.2021 | Optina Diagnostics Closes CA$24.8M Series A Funding Round | Optina Diagnostics, a Montreal, Canada-based innovative diagnostics company leader in Retinal Imaging, Brain Health and Systemic Disease detection, closed a CA$24.8m Series-A funding round. The round was led by DigitalDx Ventures with parti... |
| 22.09.2021 | Meet Michele Colucci, founder and managing partner at DigitalDx Ventures | DigitalDx Ventures invests in AI and data enabled diagnostics companies Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups th... |
| 02.09.2021 | DIAGNOS : 2021-09-02, DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer's Disease Test – Download ... | 2021.09.02 DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer's Disease Test BROSSARD, Quebec, Canada, September 2nd, 2021 - (GLOBE NEWSWIR... |
Show more